Study to Assess MEDI4736 With Either AZD9150 or AZD5069 in Advanced Solid Tumors & Relapsed Metastatic Squamous Cell Carcinoma of Head & Neck

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

August 6, 2015

Primary Completion Date

February 28, 2020

Study Completion Date

August 12, 2025

Conditions
Advanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and Neck
Interventions
DRUG

AZD9150

AZD9150

DRUG

MEDI4736

MEDI4736

DRUG

AZD5069

AZD5069

DRUG

tremelimumab (treme)

tremelimumab

Trial Locations (44)

1000

Research Site, Brussels

1200

Research Site, Brussels

1307

Research Site, Dresden

2020

Research Site, Antwerp

2650

Research Site, Edegem

5000

Research Site, Namur

12200

Research Site, Berlin

20133

Research Site, Milan

20246

Research Site, Hamburg

22031

Research Site, Fairfax

28040

Research Site, Madrid

28041

Research Site, Madrid

30625

Research Site, Hanover

33324

Research Site, Plantation

34232

Research Site, Sarasota

35294

Research Site, Birmingham

45004

Research Site, Toledo

47905

Research Site, Lafayette

48201

Research Site, Detroit

50670

Research Site, Cologne

59101

Research Site, Billings

60488

Research Site, Frankfurt

77030

Research Site, Houston

80218

Research Site, Denver

81675

Research Site, München

90024

Research Site, Los Angeles

90089

Research Site, Los Angeles

91010

Research Site, Duarte

92093

Research Site, La Jolla

94158

Research Site, San Francisco

98109

Research Site, Seattle

92868-3298

Research Site, Orange

02111

Research Site, Boston

07960

Research Site, Morristown

45267-2827

Research Site, Cincinnati

07743

Research Site, Jena

08035

Research Site, Barcelona

08907

Research Site, Hospitalet deLlobregat

B15 2TH

Research Site, Birmingham

SE1 9RT

Research Site, London

SW3 6JB

Research Site, London

M20 4BX

Research Site, Manchester

SM2 5PT

Research Site, Surrey

TA1 5DA

Research Site, Taunton

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

MedImmune LLC

INDUSTRY

lead

AstraZeneca

INDUSTRY